Related News
UK eyes 'three-parent' IVF to avoid disease
Source: AFP |
September 18, 2012, Tuesday
|
Print Edition
Print Edition
A fertility technique that uses DNA from three parents to create an embryo could become legal in Britain after a public consultation on its ethical implications was launched yesterday.
The results of the consultation will help inform a decision by the government on whether to legalize the technique as early as next year - potentially making Britain the first country in the world to hold human trials into the treatment, the Daily Telegraph reported. The United States is also testing the technique in laboratories.
The IVF-based technique is designed to avoid serious mitochondrial diseases inherited on the maternal side, such as muscular dystrophy, by replacing some of the mitochondrial DNA with healthy DNA from the so-called "third parent."
One in 200 children are born each year with a form of disease in their mitochondrial DNA, the structures within cells that convert energy from food into a form that the body can use.
Many of those children have mild to no symptoms, and may never even have the disease diagnosed, the Human Fertilisation and Embryology Authority, which is overseeing the consultation, said in a statement.
Others can have severe, or even life-shortening, symptoms such as muscular weakness or heart disease. Up to one in 6,500 people born in Britain each year suffer severe symptoms.
Scientists are developing a technique to remove some of the mitochondrial DNA of the mother and replace it with DNA from the "third parent" to create a healthy embryo.
All of a human's visible characteristics are encoded in DNA found in the cell nucleus, so any child born using the technique under consideration will only bear the features of two parents.
The technique is currently lawful in a laboratory but the embryos cannot be used in treatment, the HFEA revealed, calling the treatment "uncharted territory."
"Any child born following mitochondria replacement would share DNA with three people, albeit a tiny amount with the donor," the organization said in a statement.
"These changes would affect the germ line, meaning the donor's mitochondrial DNA would be passed on to future generations."
Chairman Lisa Jardine said: "We find ourselves in uncharted territory, balancing the desire to help families have healthy children with the possible impact on the children themselves and wider society."
Jardine called the decision one of "enormous public interest."
It furthers the debate on "designer babies" and the morality of engineering embryos which was first fuelled by the original forays into in-vitro fertilization treatment.
There are also fears over how the "third parent" would affect the child's sense of identity, and what rights both the child and the third parent would have.
The consultation will run until December 7.
The results of the consultation will help inform a decision by the government on whether to legalize the technique as early as next year - potentially making Britain the first country in the world to hold human trials into the treatment, the Daily Telegraph reported. The United States is also testing the technique in laboratories.
The IVF-based technique is designed to avoid serious mitochondrial diseases inherited on the maternal side, such as muscular dystrophy, by replacing some of the mitochondrial DNA with healthy DNA from the so-called "third parent."
One in 200 children are born each year with a form of disease in their mitochondrial DNA, the structures within cells that convert energy from food into a form that the body can use.
Many of those children have mild to no symptoms, and may never even have the disease diagnosed, the Human Fertilisation and Embryology Authority, which is overseeing the consultation, said in a statement.
Others can have severe, or even life-shortening, symptoms such as muscular weakness or heart disease. Up to one in 6,500 people born in Britain each year suffer severe symptoms.
Scientists are developing a technique to remove some of the mitochondrial DNA of the mother and replace it with DNA from the "third parent" to create a healthy embryo.
All of a human's visible characteristics are encoded in DNA found in the cell nucleus, so any child born using the technique under consideration will only bear the features of two parents.
The technique is currently lawful in a laboratory but the embryos cannot be used in treatment, the HFEA revealed, calling the treatment "uncharted territory."
"Any child born following mitochondria replacement would share DNA with three people, albeit a tiny amount with the donor," the organization said in a statement.
"These changes would affect the germ line, meaning the donor's mitochondrial DNA would be passed on to future generations."
Chairman Lisa Jardine said: "We find ourselves in uncharted territory, balancing the desire to help families have healthy children with the possible impact on the children themselves and wider society."
Jardine called the decision one of "enormous public interest."
It furthers the debate on "designer babies" and the morality of engineering embryos which was first fuelled by the original forays into in-vitro fertilization treatment.
There are also fears over how the "third parent" would affect the child's sense of identity, and what rights both the child and the third parent would have.
The consultation will run until December 7.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
